1. Home
  2. GOSS vs CPHC Comparison

GOSS vs CPHC Comparison

Compare GOSS & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.43

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo Canterbury Park Holding Corporation 'New'

CPHC

Canterbury Park Holding Corporation 'New'

N/A

Current Price

$15.85

Market Cap

83.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
CPHC
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
83.3M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
GOSS
CPHC
Price
$0.43
$15.85
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$4.91
N/A
AVG Volume (30 Days)
25.1M
1.2K
Earning Date
03-17-2026
03-09-2026
Dividend Yield
N/A
1.77%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,471,000.00
$59,227,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.14
52 Week Low
$0.33
$14.49
52 Week High
$3.87
$21.61

Technical Indicators

Market Signals
Indicator
GOSS
CPHC
Relative Strength Index (RSI) 23.44 56.05
Support Level $0.33 $14.98
Resistance Level $0.60 $16.02
Average True Range (ATR) 0.06 0.16
MACD 0.06 0.02
Stochastic Oscillator 22.86 100.00

Price Performance

Historical Comparison
GOSS
CPHC

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: